A positive feedback loop between RIP 3 and JNK controls non‐alcoholic steatohepatitis-Reference-Cited by-同舟云学术

A positive feedback loop between RIP 3 and JNK controls non‐alcoholic steatohepatitis

Published:2014-06-24 Issue:8 Volume:6 Page:1062-1074
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Gautheron Jérémie¹²,Vucur Mihael¹,Reisinger Florian³,Cardenas David Vargas¹,Roderburg Christoph¹,Koppe Christiane¹,Kreggenwinkel Karina¹,Schneider Anne Theres¹,Bartneck Matthias¹,Neumann Ulf Peter⁴,Canbay Ali⁵,Reeves Helen Louise⁶,Luedde Mark⁷,Tacke Frank¹,Trautwein Christian¹,Heikenwalder Mathias³,Luedde Tom¹

Affiliation:

1. Department of Gastroenterology Digestive Diseases and Intensive Care Medicine (Department of Medicine III) University Hospital RWTH Aachen Aachen Germany

2. Interdisciplinary Centre for Clinical Research Aachen University Hospital RWTH Aachen Aachen Germany

3. Institute of Virology Technische Universität München and Helmholtz Zentrum München für Gesundheit und Umwelt (HMGU) Munich Germany

4. Department of Visceral and Transplantation Surgery University Hospital RWTH Aachen Aachen Germany

5. Department of Gastroenterology and Hepatology University Hospital University Duisburg‐Essen Essen Germany

6. The Liver Group Department of Medicine Freeman Hospital Newcastle‐upon‐Tyne Hospitals NHS Foundation Trust Newcastle‐upon‐Tyne UK

7. Department of Cardiology and Angiology University Hospital Kiel Kiel Germany

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201403856

Reference52 articles.

1. Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis

2. Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury

3. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: An international collaborative study

4. The Adaptor Protein FADD Protects Epidermal Keratinocytes from Necroptosis In Vivo and Prevents Skin Inflammation

5. Mechanisms and Biomarkers of Apoptosis in Liver Disease and Fibrosis

Cited by 258 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting cell death in NAFLD: mechanisms and targeted therapies;Cell Death Discovery;2024-09-07

2. Intricate interplay between cell metabolism and necroptosis regulation in metabolic dysfunction-associated steatotic liver disease: A narrative review;Metabolism;2024-09

3. Dual roles of inflammatory programmed cell death in cancer: insights into pyroptosis and necroptosis;Frontiers in Pharmacology;2024-08-27

4. DNA sensors in metabolic and cardiovascular diseases: Molecular mechanisms and therapeutic prospects;Immunological Reviews;2024-08-19

5. Cell Death and Survival Mechanisms in Cholangiocarcinogenesis;The American Journal of Pathology;2024-08